Business

Announcement on Initiating Phase III Clinical Trial of Freeze-dried Live Attenuated Varicella-Zoster Vaccine (VZV-7D) and Completing Enrollment of the 1st Subject

Announcement on Initiating Phase III Clinical Trial of Freeze-dried Live Attenuated Varicella-Zoster Vaccine (VZV-7D) and Completing Enrollment of the 1st Subject

articleBeijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class AJune 19, 20255/news/announcement-on-initiating-phase-iii-clinical-trial-of-freeze-dried-live-attenuated-varicella-zoster-vaccine-vzv-7d-and-completing-enrollment-of-the-1st-subject
Announcement on Initiating Phase III Clinical Trial of Freeze-dried Live Attenuated Varicella-Zoster Vaccine (VZV-7D) and Completing Enrollment of the 1st Subject

About this update from Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A

Announcement on Initiating Phase III Clinical Trial of Freeze-dried Live Attenuated Varicella-Zoster Vaccine (VZV-7D) and Completing Enrollment of the 1st SubjectThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A